title: [Coombs-positive autoimmune hemolytic anemia as a striking initial manifestation of myelodysplastic syndromes].
authors.forename: C
authors.initials: C
authors.lastname: Sanz
authors.forename: F
authors.initials: F
authors.lastname: Cervantes
authors.forename: A
authors.initials: A
authors.lastname: Pereira
authors.forename: C
authors.initials: C
authors.lastname: Rozman
mesh_terms: D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000209:etiology* / Q000628:therapy; D000754:Anemia, Refractory, with Excess of Blasts / Q000150:complications / Q000175:diagnosis*; D001803:Blood Transfusion; D003131:Combined Modality Therapy; D003298:Coombs Test; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D013163:Splenomegaly / Q000209:etiology
chemical_list: D003520:Cyclophosphamide; D011241:Prednisone
vernacular_title: Anemia hemolítica autoinmune Coombs positiva como manifestación inicial destacada de los síndromes mielodisplásicos.